Literature DB >> 16908148

Application of azide-alkyne cycloaddition 'click chemistry' for the synthesis of Grb2 SH2 domain-binding macrocycles.

Won Jun Choi1, Zhen-Dan Shi, Karen M Worthy, Lakshman Bindu, Rajeshri G Karki, Marc C Nicklaus, Robert J Fisher, Terrence R Burke.   

Abstract

Copper (I) promoted [3+2] Huisgen cycloaddition of azides with terminal alkynes was used to prepare triazole-containing macrocycles based on the Grb2 SH2 domain-binding motif, 'Pmp-Ac(6)c-Asn', where Pmp and Ac(6)c stand for 4-phosphonomethylphenylalanine and 1-aminocyclohexanecarboxylic acid, respectively. When cycloaddition reactions were conducted at 1mM substrate concentrations, cyclization of monomeric units occurred. At 2mM substrate concentrations the predominant products were macrocyclic dimers. In Grb2 SH2 domain-binding assays the monomeric (S)-Pmp-containing macrocycle exhibited a K(d) value of 0.23microM, while the corresponding dimeric macrocycle was found to have greater than 50-fold higher affinity. The open-chain dimer was also found to have affinity equal to the dimeric macrocycle. This work represents the first application of 'click chemistry' to the synthesis of SH2 domain-binding inhibitors and indicates its potential utility.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16908148      PMCID: PMC1624856          DOI: 10.1016/j.bmcl.2006.08.004

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  24 in total

1.  Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.

Authors:  Pierre Nioche; Wang-Qing Liu; Isabelle Broutin; Franck Charbonnier; Marie-Thérèse Latreille; Michel Vidal; Bernard Roques; Christiane Garbay; Arnaud Ducruix
Journal:  J Mol Biol       Date:  2002-02-01       Impact factor: 5.469

2.  Evaluation of macrocyclic Grb2 SH2 domain-binding peptide mimetics prepared by ring-closing metathesis of C-terminal allylglycines with an N-terminal beta-vinyl-substituted phosphotyrosyl mimetic.

Authors:  Shinya Oishi; Rajeshri G Karki; Zhen-Dan Shi; Karen M Worthy; Lakshman Bindu; Oleg Chertov; Dominic Esposito; Peter Frank; William K Gillette; Melissa Maderia; James Hartley; Marc C Nicklaus; Joseph J Barchi; Robert J Fisher; Terrence R Burke
Journal:  Bioorg Med Chem       Date:  2005-04-01       Impact factor: 3.641

3.  Utilization of a common pathway for the synthesis of high affinity macrocyclic Grb2 SH2 domain-binding peptide mimetics that differ in the configuration at one ring junction.

Authors:  Zhen-Dan Shi; Rajeshri G Karki; Karen M Worthy; Lakshman K Bindu; Marc C Nicklaus; Robert J Fisher; Terrence R Burke
Journal:  Chem Biodivers       Date:  2005-04       Impact factor: 2.408

Review 4.  Potential disease targets for drugs that disrupt protein-- protein interactions of Grb2 and Crk family adaptors.

Authors:  Stephan M Feller; Marc Lewitzky
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

5.  Ring-closing metathesis of C-terminal allylglycine residues with an N-terminal beta-vinyl-substituted phosphotyrosyl mimetic as an approach to novel Grb2 SH2 domain-binding macrocycles.

Authors:  Shinya Oishi; Zhen-Dan Shi; Karen M Worthy; Lakshman K Bindu; Robert J Fisher; Terrence R Burke
Journal:  Chembiochem       Date:  2005-04       Impact factor: 3.164

6.  Olefin metathesis in the design and synthesis of a globally constrained Grb2 SH2 domain inhibitor.

Authors:  Y Gao; C Q Wei; T R Burke
Journal:  Org Lett       Date:  2001-05-31       Impact factor: 6.005

7.  Mapping the X(+1) binding site of the Grb2-SH2 domain with alpha,alpha-disubstituted cyclic alpha-amino acids.

Authors:  C García-Echeverría; B Gay; J Rahuel; P Furet
Journal:  Bioorg Med Chem Lett       Date:  1999-10-18       Impact factor: 2.823

8.  Synthesis of a 5-methylindolyl-containing macrocycle that displays ultrapotent Grb2 SH2 domain-binding affinity.

Authors:  Zhen-Dan Shi; Kyeong Lee; Chang-Qing Wei; Lindsey R Roberts; Karen M Worthy; Robert J Fisher; Terrence R Burke
Journal:  J Med Chem       Date:  2004-02-12       Impact factor: 7.446

9.  Macrocyclization in the design of Grb2 SH2 domain-binding ligands exhibiting high potency in whole-cell systems.

Authors:  Chang-Qing Wei; Yang Gao; Kyeong Lee; Ribo Guo; Bihua Li; Manchao Zhang; Dajun Yang; Terrence R Burke
Journal:  J Med Chem       Date:  2003-01-16       Impact factor: 7.446

10.  Development of Grb2 SH2 Domain Signaling Antagonists: A Potential New Class of Antiproliferative Agents.

Authors:  Terrence R Burke
Journal:  Int J Pept Res Ther       Date:  2006-03-14       Impact factor: 1.931

View more
  7 in total

Review 1.  Targeting kinase signaling pathways with constrained peptide scaffolds.

Authors:  Laura E Hanold; Melody D Fulton; Eileen J Kennedy
Journal:  Pharmacol Ther       Date:  2017-02-07       Impact factor: 12.310

2.  Solid-phase peptide head-to-side chain cyclodimerization: discovery of C(2)-symmetric cyclic lactam hybrid α-melanocyte-stimulating hormone (MSH)/agouti-signaling protein (ASIP) analogues with potent activities at the human melanocortin receptors.

Authors:  Alexander V Mayorov; Minying Cai; Erin S Palmer; Zhihua Liu; James P Cain; Josef Vagner; Dev Trivedi; Victor J Hruby
Journal:  Peptides       Date:  2010-08-03       Impact factor: 3.750

3.  Probing the bioactive conformation of an archetypal natural product HDAC inhibitor with conformationally homogeneous triazole-modified cyclic tetrapeptides.

Authors:  W Seth Horne; Christian A Olsen; John M Beierle; Ana Montero; M Reza Ghadiri
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

4.  Conformationally homogeneous heterocyclic pseudotetrapeptides as three-dimensional scaffolds for rational drug design: receptor-selective somatostatin analogues.

Authors:  John M Beierle; W Seth Horne; Jan H van Maarseveen; Beatrice Waser; Jean Claude Reubi; M Reza Ghadiri
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

5.  Peptide cyclization and cyclodimerization by Cu(I)-mediated azide-alkyne cycloaddition.

Authors:  Reshma Jagasia; Justin M Holub; Markus Bollinger; Kent Kirshenbaum; M G Finn
Journal:  J Org Chem       Date:  2009-04-17       Impact factor: 4.354

6.  10-(Prop-2-yn-yl)-10H-phenothia-zine.

Authors:  Younas Aouine; Anouar Alami; Abdelilah El Hallaoui; Abdelrhani Elachqar; Hafid Zouihri
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-10-20

Review 7.  Synthesis of novel cyclopeptides containing heterocyclic skeletons.

Authors:  Fatima Hamdan; Fatemeh Tahoori; Saeed Balalaie
Journal:  RSC Adv       Date:  2018-10-03       Impact factor: 4.036

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.